Halozyme Therapeutics (HALO) Tops Q2 EPS by 6c, Offers Guidance

Go back to Halozyme Therapeutics (HALO) Tops Q2 EPS by 6c, Offers Guidance
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 107.39 -0.92 (0.85%)
Previous Close $108.31    52 Week High $18.39 
Open $107.67    52 Week Low $6.96 
Day High $108.79    P/E N/A 
Day Low $106.62    EPS $-0.58 
Volume 1,746,282